These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 18809735)
21. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. King CA; Marshall JS; Alshurafa H; Anderson R J Virol; 2000 Aug; 74(15):7146-50. PubMed ID: 10888655 [TBL] [Abstract][Full Text] [Related]
22. Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production. Yang KD; Yeh WT; Yang MY; Chen RF; Shaio MF J Med Virol; 2001 Feb; 63(2):150-7. PubMed ID: 11170052 [TBL] [Abstract][Full Text] [Related]
23. RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection. Brown MG; McAlpine SM; Huang YY; Haidl ID; Al-Afif A; Marshall JS; Anderson R PLoS One; 2012; 7(3):e34055. PubMed ID: 22479521 [TBL] [Abstract][Full Text] [Related]
24. Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection. Moi ML; Lim CK; Takasaki T; Kurane I J Gen Virol; 2010 Jan; 91(Pt 1):103-11. PubMed ID: 19776239 [TBL] [Abstract][Full Text] [Related]
25. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Jiang C; Wang Z; Ganther H; Lu J Cancer Res; 2001 Apr; 61(7):3062-70. PubMed ID: 11306488 [TBL] [Abstract][Full Text] [Related]
26. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection. Alen MM; Kaptein SJ; De Burghgraeve T; Balzarini J; Neyts J; Schols D Virology; 2009 Apr; 387(1):67-75. PubMed ID: 19264337 [TBL] [Abstract][Full Text] [Related]
27. A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells. Konishi E; Tabuchi Y; Yamanaka A J Virol Methods; 2010 Feb; 163(2):360-7. PubMed ID: 19883692 [TBL] [Abstract][Full Text] [Related]
28. Innate immune responses to dengue virus. Navarro-Sánchez E; Desprès P; Cedillo-Barrón L Arch Med Res; 2005; 36(5):425-35. PubMed ID: 16099317 [TBL] [Abstract][Full Text] [Related]
29. GDP dissociation inhibitor D4-GDI (Rho-GDI 2), but not the homologous rho-GDI 1, is cleaved by caspase-3 during drug-induced apoptosis. Essmann F; Wieder T; Otto A; Müller EC; Dörken B; Daniel PT Biochem J; 2000 Mar; 346 Pt 3(Pt 3):777-83. PubMed ID: 10698706 [TBL] [Abstract][Full Text] [Related]
30. Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Sun P; Fernandez S; Marovich MA; Palmer DR; Celluzzi CM; Boonnak K; Liang Z; Subramanian H; Porter KR; Sun W; Burgess TH Virology; 2009 Jan; 383(2):207-15. PubMed ID: 19013627 [TBL] [Abstract][Full Text] [Related]
31. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. Lin CF; Lei HY; Shiau AL; Liu CC; Liu HS; Yeh TM; Chen SH; Lin YS J Med Virol; 2003 Jan; 69(1):82-90. PubMed ID: 12436482 [TBL] [Abstract][Full Text] [Related]
32. Manganese induces apoptosis of human B cells: caspase-dependent cell death blocked by bcl-2. Schrantz N; Blanchard DA; Mitenne F; Auffredou MT; Vazquez A; Leca G Cell Death Differ; 1999 May; 6(5):445-53. PubMed ID: 10381635 [TBL] [Abstract][Full Text] [Related]
33. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. Boonnak K; Slike BM; Burgess TH; Mason RM; Wu SJ; Sun P; Porter K; Rudiman IF; Yuwono D; Puthavathana P; Marovich MA J Virol; 2008 Apr; 82(8):3939-51. PubMed ID: 18272578 [TBL] [Abstract][Full Text] [Related]
34. Induction of programmed cell death (apoptosis) by dengue virus in vitro and in vivo. Marianneau P; Flamand M; Deubel V; Desprès P Acta Cient Venez; 1998; 49 Suppl 1():13-7. PubMed ID: 10030049 [TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans. Flipse J; Wilschut J; Smit JM Traffic; 2013 Jan; 14(1):25-35. PubMed ID: 22998156 [TBL] [Abstract][Full Text] [Related]
36. Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development. Yen YT; Chen HC; Lin YD; Shieh CC; Wu-Hsieh BA J Virol; 2008 Dec; 82(24):12312-24. PubMed ID: 18842737 [TBL] [Abstract][Full Text] [Related]
37. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. Kou Z; Quinn M; Chen H; Rodrigo WW; Rose RC; Schlesinger JJ; Jin X J Med Virol; 2008 Jan; 80(1):134-46. PubMed ID: 18041019 [TBL] [Abstract][Full Text] [Related]
38. Dermal-type macrophages expressing CD209/DC-SIGN show inherent resistance to dengue virus growth. Kwan WH; Navarro-Sanchez E; Dumortier H; Decossas M; Vachon H; dos Santos FB; Fridman HW; Rey FA; Harris E; Despres P; Mueller CG PLoS Negl Trop Dis; 2008 Oct; 2(10):e311. PubMed ID: 18827881 [TBL] [Abstract][Full Text] [Related]
39. Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade. Shen SC; Chen YC; Hsu FL; Lee WR J Cell Biochem; 2003 Aug; 89(5):1044-55. PubMed ID: 12874837 [TBL] [Abstract][Full Text] [Related]
40. Antibody-enhanced binding of dengue-2 virus to human platelets. Wang S; He R; Patarapotikul J; Innis BL; Anderson R Virology; 1995 Oct; 213(1):254-7. PubMed ID: 7483271 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]